l‐Arginine Attenuates Cardiac Dysfunction, But Further Down‐Regulates α‐Myosin Heavy Chain Expression in Isoproterenol‐Induced Cardiomyopathy

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 117, Iss. 4, 2015-10 ,pp. : 251-260

John Wiley & Sons Inc

Access to resources Recommend Favorite

Familial hypertrophic cardiomyopathy caused by a de novo Gly716Arg mutation of the β-myosin heavy chain

By  

Cardiology in the Young, Vol. 27, Iss. 3, 2016-05 ,pp. : 467-472

Cambridge University Press

Access to resources Recommend Favorite

Missense Variants in Plakophilin-2 in Arrhythmogenic Right Ventricular Cardiomyopathy Patients – Disease-Causing or Innocent Bystanders?

By  

Cardiology, Vol. 115, Iss. 2, 2009-12 ,pp. : 148-154

Karger

Access to resources Recommend Favorite

Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review

By Hallett Lindsay   Foster Talia   Liu Zhimei   Blieden Marissa   Valentim Joice  

Current Medical Research and Opinion, Vol. 27, Iss. 8, 2011-08 ,pp. : 1571-1583

Informa Healthcare

Access to resources Recommend Favorite

Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland

By Jääskeläinen Pertti   Kuusisto Johanna   Miettinen Raija   Kärkkäinen Päivi   Kärkkäinen Satu   Heikkinen Sami   Peltola Paula   Pihlajamäki Jussi   Vauhkonen Ilkka   Laakso Markku  

Journal of Molecular Medicine, Vol. 80, Iss. 7, 2002-07 ,pp. : 412-422

Springer Publishing Company

Access to resources Recommend Favorite